Compare RAPP & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RAPP | PRA |
|---|---|---|
| Founded | 2022 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Property-Casualty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2024 | 2000 |
| Metric | RAPP | PRA |
|---|---|---|
| Price | $36.56 | $24.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $48.50 | $25.00 |
| AVG Volume (30 Days) | 251.7K | ★ 802.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | N/A | ★ $1,098,028,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.73 | $22.72 |
| 52 Week High | $42.27 | $24.85 |
| Indicator | RAPP | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 74.25 | 57.69 |
| Support Level | $25.48 | $23.88 |
| Resistance Level | $42.27 | $24.72 |
| Average True Range (ATR) | 1.93 | 0.17 |
| MACD | 0.60 | 0.01 |
| Stochastic Oscillator | 97.74 | 79.73 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.